Endobronchial tb for md exams 10 marks answer from this pdf only

Reading File
Running Command
Running Command
Running Command
Running Command
Running Command
I now have all the content needed. Here is the comprehensive 10-mark exam answer on Endobronchial Tuberculosis, sourced entirely from the attached Sharma Mohan textbook (Chapter 12, pages 160-170):

Endobronchial Tuberculosis (10 Marks)

Definition and Introduction

Endobronchial TB (EBTB) refers to the involvement of the trachea and bronchi by tuberculosis. It was first described in 1689 by Richard Morton but remained mainly a post-mortem diagnosis until the advent of bronchoscopy in the late 1920s. With effective chemotherapy, its reported frequency declined dramatically, but the resurgence of TB in the 1990s renewed interest in this entity.

Epidemiology

  • Prevalence in autopsy studies: 3% to 72%; most series report ~40%.
  • Prevalence in bronchoscopic studies: 10%-20% of active TB patients (older studies); lower in recent studies due to timely chemotherapy.
  • In non-endemic areas, current prevalence may be as low as 0.18%.
  • Most common in 21-40 years of age, though also seen in the elderly.
  • Female preponderance - attributed to voluntary cough suppression for socio-cultural reasons, allowing sputum implantation into airways; smaller airway calibre in women also contributes.

Pathophysiology - Mechanisms of Endobronchial Infection

Five mechanisms are proposed:
  1. Direct extension from the lung - bronchi adjacent to infected lung parenchyma are directly involved; tracheobronchial ulceration is more common near extensive parenchymal TB.
  2. Implantation from infected sputum - organisms from cavities are deposited onto the bronchial mucosa; the contralateral bronchial wall at the opening of a diseased lobe is typically affected.
  3. Haematogenous dissemination - uncommon; rarely described in miliary TB.
  4. Lymphatic spread - retrograde passage of tubercle bacilli through lymphatics from bronchioles upward; however, Auerbach's data suggests this is not a common mechanism.
  5. As part of primary infection - lymph node erosion into a bronchus; the inflamed lymph node attaches to the bronchial wall and infects the mucosal lining. This mechanism predominantly occurs in children.

Pathology

Macroscopic Appearance:
  • Earliest sign: erythematous mucous membranes.
  • Discrete tubercles → shallow ulcers → deep ulcers involving the bronchial wall.
  • Extensive granulation tissue may form a tumour-like mass mimicking a neoplasm.
  • Healing leads to fibrosis and bronchial stenosis (also from oedema or extrinsic lymph node compression).
  • Ulcers are 1-5 mm, long axis parallel to cartilaginous rings; more common near the carina and the posterior surface.
Microscopic Appearance:
  • Early: small oval/round epithelioid granulomas (with or without caseation) in the subepithelial region and around mucous glands.
  • Advanced: foci extend to adventitia; cartilage involvement occurs only in very extensive cases.
  • Rupture of submucosal foci → ulceration → granulation tissue with fibrin pseudomembrane → healing by connective tissue replacement → stenosis if circumferential.

Clinical Features

  • In adults: may occur in primary or reactivation TB.
  • In children: usually a complication of primary TB.
  • Barking cough - most common symptom.
  • Dyspnoea, chest pain, fever, weight loss, haemoptysis.
  • Localised fixed wheeze (low-pitched, constantly present over the same area) - characteristic.
  • Bronchorrhea (>500 mL/day) - rare.
  • Presentations include: acute respiratory failure, subacute mimicking asthma/pneumonia/foreign body aspiration, or insidious mimicking lung cancer.
  • Unusual findings: expectoration of bronchial cartilages, right-left main bronchi fistula.
  • Symptoms may appear years after treatment of pulmonary TB.
Bronchial stenosis is the most significant complication - may present as slowly progressive dyspnoea years later; can cause respiratory failure and death.

Investigations

Sputum Examination

Low yield of 15%-20% for AFB smear due to mucus entrapment by granulation tissue. Negative smear does not exclude diagnosis.

Chest Radiograph

  • 10%-20% may have a normal chest radiograph.
  • Findings: patchy infiltrates, collapse (25%-35%), consolidation (35%-60%), hyperinflation, cavities, pleural effusion, miliary infiltrates, mediastinal lymphadenopathy.

CT Chest

Very important tool. Findings include:
  • Tree-in-bud pattern (centrilobular nodules connected to branching linear opacities) - reflects plugging of small airways with mucus/pus, dilated bronchioles, and peribronchiolar inflammation.
  • Stenosis or obstruction of major airways; peribronchial soft tissue cuff.
  • Active stage: irregular, circumferential luminal narrowing.
  • Fibrotic stage: smooth or irregular narrowing with less wall thickening.
  • Enlarged lymph nodes, segmental collapse, cavities, mucoid impaction.
  • CT is inaccurate in distinguishing endobronchial, submucosal, or extrinsic disease.
  • Cannot reliably differentiate from bronchogenic carcinoma - bronchoscopy is ultimately needed.

Spirometry

Most common abnormality: restriction (47%); obstructive in 5.9%; mixed in 23.5%; normal in 23.5%. Unlike asthma, no increased bronchial hyperreactivity.

Bronchoscopy - Gold Standard

Bronchoscopy is the gold standard for diagnosis. It is indicated in:
  • TB suspects with three negative smears.
  • Diagnosed TB with refractory cough, localised wheeze, persistent dyspnoea, diminished breath sounds, radiographic atelectasis, or failure to respond to anti-TB treatment.
Bronchoscopic biopsies show granulomas (non-necrotic to necrotic, with or without AFB). Brushings + biopsy increases diagnostic yield.
Bronchostenosis develops in 50%-90% of patients despite effective therapy.

Seven Bronchoscopic Types (Chung and Lee Classification)

TypeDescriptionFibrostenosis Risk
Non-specific bronchiticMild mucosal swelling/hyperaemiaGood prognosis; resolves in 2 months
GranularScattered grains of boiled rice appearance; severe inflammatory changes20%
Oedematous-hyperaemicSevere mucosal swelling + hyperaemia with luminal narrowing60% (2-3 months); 30% complete obstruction
Actively caseatingDiffuse whitish cheese-like material on hyperaemic mucosa65% (most common type)
UlcerativeUlcers in the tracheobronchial treeGood prognosis; resolves in 3 months
FibrostenoticMarked luminal narrowing due to fibrosisNo response to treatment; may progress to complete obstruction
TumourousEndobronchial mass, often with caseous material; mimics lung cancer70% (most unpredictable)
Different subtypes can coexist in the same patient. One subtype may transform into another, except the fibrostenotic subtype.

Differential Diagnosis

  • Bronchial asthma (most common misdiagnosis)
  • Lung cancer / bronchogenic carcinoma
  • Foreign body aspiration (especially in children)
  • Atypical mycobacterial infection, sarcoidosis, actinomycosis, papillomatosis
  • Wegener's granulomatosis, relapsing polychondritis, amyloidosis, rhinoscleroma
  • Anthracofibrosis (non-smoking elderly women exposed to biomass fuel; co-exists with TB but spares central airways)

Treatment

1. Anti-TB Chemotherapy

Same regimen as pulmonary TB (standard 6-month DOTS regimen). Inhaled streptomycin and inhaled isoniazid have been reported as adjuncts but lack large RCT validation.

2. Corticosteroids

  • Used empirically to suppress barking cough.
  • No strong evidence that corticosteroids prevent bronchostenosis (one RCT in adults showed no benefit).
  • May be beneficial in children with lymph node TB causing bronchial obstruction (small double-blind studies).
  • Not recommended for routine use.

3. Bronchoscopic Interventions (for airway stenosis)

  • Mechanical dilatation: balloon bronchoplasty (radial force, less mucosal trauma; useful for short stenotic segments).
  • Debulking: rigid bronchoscope; curettage with forceps.
  • Thermal debulking: electrocautery, Argon Plasma Coagulation (APC) - FiO₂ must be <40%; effective in symptomatic obstruction.
  • Nd-YAG / CO₂ Laser: Nd-YAG preferred (tissue vaporisation + coagulation); FiO₂ <40%.
  • Cryotherapy: freeze-thaw cycles; safe (cartilage is cryoresistant); no airway fire risk.
  • Airway stents:
    • Silicon stents: preferred; require rigid bronchoscopy; higher migration but easier to remove.
    • Metal stents: should be avoided (FDA black-box warning 2005 for benign stenosis); granulation tissue ingrowth, difficult to remove, frequent complications.
    • Hybrid (covered metal) stents: prevent ingrowth but higher migration.
    • Stents kept for 6-18 months in benign stenosis.

4. Surgery

  • Sleeve resection (bronchoplasty with end-to-end anastomosis) - low mortality with modern techniques.
  • Lobectomy for lobar/segmental bronchi involvement.
  • Pneumonectomy as last resort for extensive bronchiectasis or completely obliterated main-stem bronchus.
  • Ideally performed when active disease is no longer present.

Special Situations

  • Children: incidence 40%-60%; primarily from lymph node erosion into bronchus; most common bronchoscopic finding is extrinsic compression; corticosteroids show some benefit.
  • Elderly: at least 15%; often diagnosed during work-up for lung cancer; 60% develop bronchial stenosis.
  • HIV: tumorous form more common (due to lymph node erosion); progressive bronchostenosis not commonly reported.
  • Pregnancy: hormonal/vascular changes worsen airway stenosis; Heliox (79% He + 21% O₂) can reduce work of breathing; airway intervention preferably earlier in pregnancy.
  • IRIS: paradoxical worsening; endobronchial extension of inflamed mediastinal lymph nodes in HIV-positive patients on ART.

Key Points for Exam

  • EBTB is underdiagnosed because 10%-20% have normal CXR and sputum smear yield is only 15%-20%.
  • Bronchoscopy is the gold standard and is both diagnostic and prognostic.
  • Fibrostenosis is the most feared complication (occurs in 50%-90% despite therapy).
  • Most common form: actively caseating; worst prognosis: tumourous type.
  • Risk factors for persistent airway stenosis: age >45 years, anti-TB treatment delayed >90 days after initial symptoms.
  • Multidisciplinary approach (interventional pulmonologist, thoracic surgeon, radiologist, TB specialist) is ideal.
(All content sourced from: Sharma Mohan - Textbook of Tuberculosis and Nontuberculous Mycobacterial Diseases, Chapter 12 - Endobronchial Tuberculosis, pp. 160-170)

Just name complications

From the same PDF (Chapter 12), the complications of Endobronchial TB are:
  1. Bronchostenosis / Bronchial stenosis - most significant complication (50%-90% despite effective therapy)
  2. Atelectasis / Lung collapse
  3. Bronchiectasis
  4. Post-obstructive pneumonia
  5. Lung abscess
  6. Obstructive emphysema / Hyperinflation
  7. Respiratory failure
  8. Tension pneumothorax (from partial obstruction acting as one-way valve)
  9. Tracheostomy / difficult endotracheal intubation (from tracheal stenosis)
  10. Death by suffocation (from severe tracheal stenosis)
  11. Pseudomembranous tracheobronchial aspergillosis (on stenotic area)
  12. Fistula formation (between right and left main bronchi)
  13. Expectoration of bronchial cartilages
  14. Tract TB - concomitant intestinal and laryngeal involvement (Auerbach)
This is a shared conversation. Sign in to Orris to start your own chat.